14.28EUR+1.28%Mkt Cap: 785.20M $P/E: —Today
Genfit S.A., together with its subsidiaries, engages in the research and development of medicines and diagnostic solutions in France and internationally. The company offers elafibranor for the treatment of primary biliar…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap785.20M $
Enterprise Value820.58M $
Revenue (TTM)77.01M $
Gross Profit70.80M $
Net Income (TTM)-93.44M $
Revenue/Share1.545 USD
Last Price14.28 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees161
CountryFR
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)16.83
PEG—
EV/EBITDA-14.59
EV/Revenue10.66
P/S9.97
P/B-31.26
EPS (TTM)-1.72
EPS (Forward)0.84
52W Range
3.04890% of range15.48
52W High15.48 EUR
52W Low3.048 EUR
Profitability
Gross Margin99.54%
Oper. Margin-151.88%
EBITDA Margin-73.03%
Profit Margin-131.38%
ROE381.47%
ROA-54.05%
Growth
Revenue Growth268.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-28.52M $
CapEx (TTM)3.72M $
FCF Margin-83.83%
FCF Yield-8.22%
Net Debt53.91M $
Net Debt/EBITDA-0.96
Balance Sheet
Debt/Equity-6.69
Current Ratio2.00
Quick Ratio1.96
Book Value/Sh-0.4510 EUR
Cash/Share2.021 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)15.90 EUR
Upside (mean)+11.3%
Target Range15.00 EUR – 18.60 EUR
€15.00+11.3% to mean€18.60
# Analysts4
Ownership
Shares Out.50.10M
Float41.07M
Insiders13.22%
Institutions9.58%
Technical
SMA 5012.47 (+14.5%)
SMA 2008.374 (+70.5%)
Beta1.14
S&P 52W Chg18.16%
Avg Vol (30d)300.67K
Avg Vol (10d)252.91K
Technical Indicators
RSI (14)56.6
MACD0.3501
MACD Signal0.3878
MACD Hist.-0.0378
BB Upper14.71 EUR
BB Middle13.70 EUR
BB Lower12.69 EUR
BB Width14.73%
ATR (14)0.7592 EUR
Vol Ratio (20d)0.98x